Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.

Recent Press Releases

January 26, 2015 - 1:00 a.m.
Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic AgentPrinter Friendly Version 

Upcoming Events

Monday, February 23, 2015 through Thursday, February 26, 2015
Conference on Retroviruses and Opportunistic Infections (CROI)
LocationSeattle, WA

Most Viewed Links

Updated 01/27/15
1.Earnings
2.SEC Filings
3.Stock Information
4.Fundamentals - Snapshot
5.Annual Reports
* Data collected 01/19/15 - 01/26/15

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$107.11
 Stock is Up 1.57 (1.49%)
Data as of 01/26/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Q3 2014 Gilead Sciences Earnings Conference Call

October 28, 2014 4:30 p.m. ET
Play